Kilitch Drugs — promoter holding and stake value

Pharmaceuticals & Biotechnology

The promoter group of Kilitch Drugs holds 63.77% of the company. At a market capitalisation of ₹707 cr, that holding is worth ₹451 cr.

Promoter stake

63.77%

Value of holding

₹451 cr

Market cap

₹707 cr

Stake change

-4.56%

Promoter stake, quarter by quarter

QuarterHoldingStake %Pledged
Q3-2021
68.33%—
Q4-2021
68.25%—
Q1-2022
68.25%—
Q2-2022
68.25%—
Q3-2022
68.25%—
Q4-2022
68.25%—
Q1-2023
68.25%—
Q2-2023
68.25%—
Q3-2023
69.23%—
Q4-2023
69.23%—
Q1-2024
69.23%—
Q2-2024
69.23%—
Q3-2024
69.23%—
Q4-2024
69.23%—
Q1-2025
69.23%—
Q2-2025
69.23%—
Q3-2025
63.77%—
Q4-2025
63.77%—
Q1-2026
63.77%—
Q2-2026
63.77%—
Q3-2026
63.77%—

Promoter holdings in Pharmaceuticals & Biotechnology

What this figure is, and is not

The value shown is Kilitch Drugs's disclosed promoter shareholding multiplied by its current market capitalisation. The shareholding percentage comes from the quarterly pattern filed with the exchanges; the market cap moves daily, so this value moves daily.

A promoter group is usually a family, trust or holding company rather than one individual, and this figure covers only this one listed company. It is not an estimate of any person's net worth, and it excludes any other assets, holdings or liabilities.